Atovaquone
Pricing Report NDC 66993-062-72

Latest NADAC: $1.41361 per ML · Effective Feb 17, 2021 · Est. package price $296.86 (210 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Atovaquone (NDC 66993-062-72) is $1.41361 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 17, 2021.

As a provided by Prasco Laboratories, this medication is distributed in a 1 BOTTLE in 1 CARTON / 210 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.41361
Per ML

Effective Date
Feb 17, 2021
Billable Units
210 ML
Estimated Package Price
$296.86
Data Status
As of Feb 24, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 210 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2014, the NADAC wholesale price for (NDC ) has moved within a range of $1.00664 to $4.51596 per ML. Over this 6 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.0066 - $4.5160
Market Volatility
348.62% Variance
Latest Trend
9.68%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 17, 2021 $1.41361 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $1.56509 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $1.00664 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $1.35128 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $1.27829 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $1.72168 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $1.62856 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $1.49167 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 17, 2020 $1.72992 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2020 $1.77466 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2020 $1.87157 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 18, 2020 $1.75242 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026